+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Takepron"

Takepron - API Insight, 2022 - Product Thumbnail Image

Takepron - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Takepron- Drug Insight, 2019 - Product Thumbnail Image

Takepron- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Takepron market is a segment of the pharmaceutical industry focused on the development and sale of drugs used to treat gastrointestinal disorders. These drugs are used to treat a wide range of conditions, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Takepron drugs are typically prescribed by physicians and are available in both prescription and over-the-counter forms. The Takepron market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Other companies in the market include AbbVie, AstraZeneca, and Takeda. These companies are constantly innovating and developing new drugs to meet the needs of patients. Show Less Read more